220 Stocks to Sell Today
Free Report for Zacks.com
Visitors Only

Overall, Zacks Rank #5 Strong Sells perform 6X worse than the market. Are any of these portfolio killers lurking among the stocks you're holding or considering? Find out today for free.


No cost, no obligation to buy anything ever.
Privacy Policy
Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/19/2013

Company Name Symbol %Change
SONIC FOUNDR SOFO
4.40%
SUPPORTCOM I SPRT
3.75%
UNISYS CORP UIS
3.31%
SHORETEL INC SHOR
3.22%
GREEN MOUNTA GMCR
3.13%

American Vanguard Tops in 4Q

by Zacks Equity Research

March 07, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Specialty chemicals maker American Vanguard Corp. (AVD - Snapshot Report) witnessed a healthy rise in its fourth-quarter 2012 profit on the back of continued strong market demand for its products.

The Newport Beach, Calif.-based company raked in earnings of 39 cents a share in the quarter, which beat the Zacks Consensus Estimate by 4 cents and exceeded the year-ago quarter’s earnings of 23 cents.

Profit soared roughly 77% year over year to $11.3 million in the quarter, buoyed by healthy demand of American Vanguard's crop protection products. American Vanguard is leveraging the growing demand for soil insecticides as the U.S. corn growers contend with pest problems.

For full-year 2012, earnings climbed to $1.28 per share from 79 cents per share in 2011, also topping the Zacks Consensus Estimate of $1.22.

Revenues climbed 28% year over year to $104.3 million in the reported quarter, beating the Zacks Consensus Estimate of $101 million.

For the full year, revenues jumped 22% year over year to $366.2 million, backed by strong traction of American Vanguard’s Yield Enhancing Solutions (YES). Sales beat the Zacks Consensus Estimate of $363 million.

Gross margin rose to 44% in 2012 from 41% a year ago. Operating expenses for the year climbed 22% year over year to $101.8 million. Operating margin rose to 16.2% in 2012 from 13% in 2011 as a healthy increase in revenues more than offset higher operating costs.

American Vanguard exited 2012 with cash of $38.5 million, up roughly 10% year over year. Total long-term debt increased 39% year over year to $130 million. Operating cash flow for the year rose roughly 3% year over year to $40.4 million.

American Vanguard is optimistic about 2013 and feels that it is well placed to meet the increasing demand for soil insecticides by maintaining full production of its products and proprietary equipment systems. The successful roll out of its herbicide co-marketing program with Monsanto (MON - Analyst Report) is also expected to support its results.

American Vanguard makes specialty chemical products for agricultural and commercial applications. The company develops and markets an array of chemicals, including insecticides, fungicides and herbicides, for crops, human and animal health protection. American Vanguard has the largest assortment of corn soil insecticides coupled with the most advanced dispensing equipment.

American Vanguard currently carries a Zacks Rank #3 (Hold).

Other companies in the specialty chemicals industry with a favorable Zacks Rank are Novozymes A/S (NVZMY) and Penford Corporation (PENX - Snapshot Report). Both hold a Zacks Rank #1 (Strong Buy).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.